Cargando…
Author Correction: The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042211/ https://www.ncbi.nlm.nih.gov/pubmed/32099023 http://dx.doi.org/10.1038/s41598-020-60957-9 |
_version_ | 1783501264615636992 |
---|---|
author | Hsieh, Ming-Chia Tsai, Wan-Hua Jheng, Yu-Pang Su, Shih-Li Wang, Shu-Yi Lin, Chi-Chen Chen, Yi-Hsing Chang, Wen-Wei |
author_facet | Hsieh, Ming-Chia Tsai, Wan-Hua Jheng, Yu-Pang Su, Shih-Li Wang, Shu-Yi Lin, Chi-Chen Chen, Yi-Hsing Chang, Wen-Wei |
author_sort | Hsieh, Ming-Chia |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7042211 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-70422112020-03-03 Author Correction: The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial Hsieh, Ming-Chia Tsai, Wan-Hua Jheng, Yu-Pang Su, Shih-Li Wang, Shu-Yi Lin, Chi-Chen Chen, Yi-Hsing Chang, Wen-Wei Sci Rep Author Correction Nature Publishing Group UK 2020-02-26 /pmc/articles/PMC7042211/ /pubmed/32099023 http://dx.doi.org/10.1038/s41598-020-60957-9 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Author Correction Hsieh, Ming-Chia Tsai, Wan-Hua Jheng, Yu-Pang Su, Shih-Li Wang, Shu-Yi Lin, Chi-Chen Chen, Yi-Hsing Chang, Wen-Wei Author Correction: The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial |
title | Author Correction: The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial |
title_full | Author Correction: The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial |
title_fullStr | Author Correction: The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial |
title_full_unstemmed | Author Correction: The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial |
title_short | Author Correction: The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial |
title_sort | author correction: the beneficial effects of lactobacillus reuteri adr-1 or adr-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial |
topic | Author Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042211/ https://www.ncbi.nlm.nih.gov/pubmed/32099023 http://dx.doi.org/10.1038/s41598-020-60957-9 |
work_keys_str_mv | AT hsiehmingchia authorcorrectionthebeneficialeffectsoflactobacillusreuteriadr1oradr3consumptionontype2diabetesmellitusarandomizeddoubleblindedplacebocontrolledtrial AT tsaiwanhua authorcorrectionthebeneficialeffectsoflactobacillusreuteriadr1oradr3consumptionontype2diabetesmellitusarandomizeddoubleblindedplacebocontrolledtrial AT jhengyupang authorcorrectionthebeneficialeffectsoflactobacillusreuteriadr1oradr3consumptionontype2diabetesmellitusarandomizeddoubleblindedplacebocontrolledtrial AT sushihli authorcorrectionthebeneficialeffectsoflactobacillusreuteriadr1oradr3consumptionontype2diabetesmellitusarandomizeddoubleblindedplacebocontrolledtrial AT wangshuyi authorcorrectionthebeneficialeffectsoflactobacillusreuteriadr1oradr3consumptionontype2diabetesmellitusarandomizeddoubleblindedplacebocontrolledtrial AT linchichen authorcorrectionthebeneficialeffectsoflactobacillusreuteriadr1oradr3consumptionontype2diabetesmellitusarandomizeddoubleblindedplacebocontrolledtrial AT chenyihsing authorcorrectionthebeneficialeffectsoflactobacillusreuteriadr1oradr3consumptionontype2diabetesmellitusarandomizeddoubleblindedplacebocontrolledtrial AT changwenwei authorcorrectionthebeneficialeffectsoflactobacillusreuteriadr1oradr3consumptionontype2diabetesmellitusarandomizeddoubleblindedplacebocontrolledtrial |